|
Roy H Hammerstedt, PhD; President. Email:
Hammer@apdls.com - He
received his academic training at the University of Minnesota, spent two years at Michigan State University, before joining
the faculty in Biochemistry at The Pennsylvania State University. Over a 30 year period he progressed through the ranks, retiring
from his academic responsibilities at the end of 1999 as Professor Emeritus of Biochemistry. His distinguished academic career
was marked by: (a) residence as visiting professor at both University of Wisconsin and Cornell University, interacting with
members of the US National Academy of Sciences; (b) service in elected and appointed officer positions in two different scientific
societies; (c) publication of over a hundred scientific articles and book chapters; (d) inventor or co-inventor of pending/issued
USA patents [plus foreign counterparts]; (e) consultancy to both the National Institutes of Health and United States Department
of Agriculture; (f) continuous receipt of millions of dollars in competitive federal funding over a 30 year period; and (g)
mentorship to dozens of students, postdoctoral fellows and visiting professors from around the world.
- He attained leadership in membrane biophysics, cell function and cell storage as
recognized by election as a Fellow in the Section on Chemistry of The American Association for the Advancement of Science
in 2000.
- As a member of the NASA supported "Center for
the Commercialization of Space", he invented and developed a unique cell sampling device operational in low gravity and
served as manager of a program that integrated that package into a series of suborbital test flights and a "shuttle"
mission.
- In 1987 he co-founded BioPore and directed its activities
through 2001, assuming responsibilities in areas of scientific development, overall management, fund raising, recruitment
of members of Board of Directors, negotiation of contracts with major biomedical and agricultural companies, engagement of
investment banks and financial consultants, evaluating acquisition candidates, and overall business strategy.
- In 2003 he formed APD Life Sciences to
focus on the critical role of early prototype/process development in the commercialization of basic research in the life sciences.
|
